45X-84492-71470

3 vaccinations 10 coded responses 31 check-ins 10 free-text entries 0 call cases

Sex: Female
Age at first dose: 41-45
ZIP prefix: 598 / MT
Registered: 2021-04-09

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Registered dependents

4XS-21853-34428 Child or adolescent in my care · Female · 2021-11-06

Timeline Vaccinations Free text MedDRA terms

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-19
Dose 1 — Pfizer-BioNTech
2021-04-09
Registered in v-safe
2021-04-09
Dose 2 — Pfizer-BioNTech
2021-04-09
Survey response — day 0, dose 2
MedDRA: Pre-existing disease — Feeling: Fair · Fatigue or tiredness

Free text: ipsilateral dysesthias (from multiple sclerosis)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-10
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-04-11
Survey response — days 1–6 daily, dose 2
MedDRA: Axillary pain, Dysgeusia, Lymphadenopathy, Taste disorder — Feeling: Good

Free text: ipsilateral axillary lymphadenopathy with associated axillary pain, taste disturbances (metallic taste)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-12
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-13
Survey response — days 1–6 daily, dose 2
MedDRA: Fatigue — Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: fatigue feels more like my usual MS fatigue than what I experienced in the first 24 hours following vaccination

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-14
Survey response — days 1–6 daily, dose 2
MedDRA: Axillary pain, Illness — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: axillary pain, which had previously resolved so Im concerned I may be sick

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-16
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-04-23
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-30
Survey response — day 21, dose 2
MedDRA: Cough, Seasonal allergy — Feeling: Good

Free text: cough - worst first thing in the morning, likely spring allergies from having the windows open

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-07
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-14
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-21
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-09
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-08
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-12-03
Dose 3 — Pfizer-BioNTech
2021-12-03
Health check-in — day 0, dose 3
Feeling: Good · None

Adult check-in
2021-12-04
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Headache, Joint pains, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-12-05
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Good · Fatigue or tiredness

Free text: ipsilateral axillary lymphadenopathy

MedDRA releases: 2024-11 · check-in free text available
2021-12-06
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-07
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Good

Free text: ipsilateral axillary lymphadenopathy

MedDRA releases: 2024-11 · check-in free text available
2021-12-08
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-09
Survey response — days 1–6 daily, dose 3
MedDRA: Neuralgia — Feeling: Good

Free text: ipsilateral axillary nerve pain

MedDRA releases: 2024-11 · check-in free text available
2021-12-10
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-12-17
Survey response — day 14, dose 3
MedDRA: Lymphadenopathy — Feeling: Good

Free text: intermittent painful ipsilateral lymphadenopathy

MedDRA releases: 2024-11 · check-in free text available
2021-12-24
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-12-31
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-01-07
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-01-14
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-03-04
Survey response — 3 months, dose 3
MedDRA: Ageusia, Anosmia, Fatigue, Multiple sclerosis, Pre-existing disease, Respiratory symptom, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school

Free text: Upper and lower respiratory symptoms, loss of taste and smell, fatigue (covid19 by PCR). Symptoms resolved without seeking medical attention within 4 days, except loss of taste which persisted for about 7 days. Unrelated MS flare 2/28 due to weather.

MedDRA releases: 2024-11 · check-in free text available
2022-06-03
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-12-05
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-19	Pfizer-BioNTech
2	2021-04-09	Pfizer-BioNTech
3	2021-12-03	Pfizer-BioNTech	No

Free text

Release 7 — day 0, dose 2

2021-04-09

Systemic reaction (other): ipsilateral dysesthias (from multiple sclerosis)

Release 7 — days 1–6 daily, dose 2

2021-04-11

Systemic reaction (other): ipsilateral axillary lymphadenopathy with associated axillary pain, taste disturbances (metallic taste)

2021-04-13

Systemic reaction (other): fatigue feels more like my usual MS fatigue than what I experienced in the first 24 hours following vaccination

2021-04-14

Systemic reaction (other): axillary pain, which had previously resolved so Im concerned I may be sick

Release 8 — day 21, dose 2

2021-04-30

Symptoms: cough - worst first thing in the morning, likely spring allergies from having the windows open

Release 10 — days 1–6 daily, dose 3

2021-12-05

Systemic reaction (other): ipsilateral axillary lymphadenopathy

2021-12-07

Systemic reaction (other): ipsilateral axillary lymphadenopathy

2021-12-09

Systemic reaction (other): ipsilateral axillary nerve pain

Release 10 — day 14, dose 3

2021-12-17

Symptoms: intermittent painful ipsilateral lymphadenopathy

Release 11 — 3 months, dose 3

2022-03-04

Symptoms: Upper and lower respiratory symptoms, loss of taste and smell, fatigue (covid19 by PCR). Symptoms resolved without seeking medical attention within 4 days, except loss of taste which persisted for about 7 days. Unrelated MS flare 2/28 due to weather. cut off by CDC

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Ageusia	·	·	✓
SD	Anosmia	·	·	✓
SD	Cough	✓	✓	✓
SD	Fatigue	·	·	✓
SD	Lymphadenopathy	·	·	✓
SD	Multiple sclerosis	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Respiratory symptom	·	·	✓
SD	SARS-CoV-2 test positive	·	·	✓
SD	Seasonal allergy	✓	✓	✓
SRO	Axillary pain	✓	✓	✓
SRO	Dysgeusia	✓	✓	✓
SRO	Fatigue	✓	✓	✓
SRO	Illness	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓
SRO	Neuralgia	·	·	✓
SRO	Pre-existing disease	✓	✓	✓
SRO	Taste disorder	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release